Corcept Therapeutics Incorporated
NASDAQ:CORT
Overview | Financials
Company Name | Corcept Therapeutics Incorporated |
Symbol | CORT |
Currency | USD |
Price | 38.11 |
Market Cap | 3,982,190,120 |
Dividend Yield | 0% |
52-week-range | 20.84 - 39.75 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Joseph K. Belanoff M.D. |
Website | https://www.corcept.com |
An error occurred while fetching data.
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD